畜牧兽医学报 ›› 2023, Vol. 54 ›› Issue (12): 5171-5183.doi: 10.11843/j.issn.0366-6964.2023.12.027

• 预防兽医 • 上一篇    下一篇

基于鸡毒支原体黏附素蛋白的表位疫苗制备及免疫效果评价

钟乐苗1, 刘秉珲2, 吴春琳1, 吴异健1,3*   

  1. 1. 福建省农林大学动物科学学院, 福州 350002;
    2. 福建农业职业技术学院, 福州 350119;
    3. 福建省兽医中药与动物保健重点实验室, 福州 350002
  • 收稿日期:2023-05-04 出版日期:2023-12-23 发布日期:2023-12-26
  • 通讯作者: 吴异健,主要从事兽医微生物学与免疫学研究,E-mail:fafuwyj@163.com
  • 作者简介:钟乐苗(1995-),女,江西赣州人,硕士生,主要从事兽医微生物学与免疫学研究,E-mail:974008105@qq.com;刘秉珲(1991-),男,福建福州人,硕士生,主要从事兽医微生物学与免疫学研究,E-mail:517876004@qq.com。
  • 基金资助:
    高校产学合作项目(2022N5001)

Preparation and Evaluation of Subunit Vaccine based on Adhesin Protein of Mycoplasma gallisepticum

ZHONG Lemiao1, LIU Binghui2, WU Chunlin1, WU Yijian1,3*   

  1. 1. College of Animal Science, Fujian Agriculture and Forestry University, Fuzhou 350002, China;
    2. Fujian Agricultural Vocational and Technical College, Fuzhou 350119, China;
    3. Fujian Key Laboratory of Traditional Chinese Veterinary Medicine and Animal Health, Fujian Agriculture And Forestry University, Fuzhou 350002, China
  • Received:2023-05-04 Online:2023-12-23 Published:2023-12-26

摘要: 旨在使用鸡毒支原体(Mycoplasma gallisepticum,MG)的黏附蛋白设计一种更安全、有效的多表位候选疫苗。本研究运用生物信息学方法对鸡毒支原体的多个黏附素蛋白(CrmA、GapA、Mgc2、PvpA)的B、T细胞表位进行预测。将筛选的抗原表位合成新的表位基因肽段(命名为mEA)。通过生物学在线软件分析了mEA的二级结构、亲水性、抗原性、三级结构。构建重组质粒pET32a-MG-mEA,经限制性内切酶(BamH Ⅰ和Hind Ⅲ)酶切鉴定及DNA测序鉴定后导入大肠杆菌BL21(DE3)进行诱导表达和纯化。Western blot验证重组蛋白与鸡MG阴性/阳性血清的反应性。纯化的MG-mEA重组蛋白与佐剂1∶1混匀,制备为多表位疫苗,通过SPF鸡免疫试验分析融合蛋白免疫原性。结果显示,mEA序列二级结构较稳定,抗原性良好。重组质粒经PCR扩增获得1 680 bp大小的目的条带,与预计相符。SDS-PAGE检测表达蛋白相对分子质量约48 ku,主要以可溶性形式存在。Western blot试验证明该蛋白反应原性良好。多表位疫苗免疫SPF鸡,经ELISA检测显示:二免后10 d各免疫组抗体水平达到最高,3个重组蛋白免疫组与PBS组相比差异均具有显著统计学意义 (P<0.05)。攻菌结果表明,MG感染明显损伤了气管黏膜结构,而重组蛋白+佐剂制备的疫苗能够有效保护MG的损伤。综上,本研究结果为研制安全有效的候选MG疫苗提供了新的途径。

关键词: 鸡毒支原体, 黏附素蛋白, 多表位疫苗, 原核表达, 免疫研究

Abstract: The aim of this study was to design a safer and more effective multi-epitope vaccine candidate using the adhesion proteins of Mycoplasma gallisepticum (MG). In this study, bioinformatics methods were used to predict B and T cell epitopes of several adhesin proteins (CrmA, GapA, Mgc2, PvpA) of MG. The screened antigenic epitopes were synthesized into a new epitope gene peptide (named mEA). The secondary structure, hydrophilicity, antigenicity, and tertiary structure of mEA were analyzed by Biology Online software. The recombinant plasmid pET32a-MG-mEA was constructed, identified by restriction endonucleases (BamH Ⅰ and Hind Ⅲ) and introduced into E. coli, BL21 (DE3) for induction of expression and purification by DNA sequencing.Western blot was used to verify the reactivity of the recombinant protein with chicken negative/positive sera. The purified MG-mEA recombinant protein was mixed 1∶1 with adjuvant and prepared as a multi-epitope vaccine and the immunogenicity of the fusion protein was analysed by SPF chicken immunoassay. The results showed that the secondary structure of the mEA sequence was relatively stable and the antigenicity was good. The recombinant plasmid was amplified by PCR to obtain the target band with a size of 1 680 bp, which was consistent with the prediction. SDS-PAGE detected that the relative molecular mass of the expressed protein was about 48 ku, mainly in soluble form. The multi-epitope vaccine immunised SPF chickens showed the highest antibody levels in all immunised groups at 10 d after the second vaccination, with statistically significant differences between the three recombinant protein immunised groups compared to the PBS group (P<0.05). The results showed that MG infection significantly damaged the tracheal mucosa structure and that the recombinant protein+adjuvant vaccine was effective in providing effective protection. In summary, the results of this study provide a new avenue for the development of a safe and effective MG vaccine candidate.

Key words: Mycoplasma gallisepticum, adhesin proteins, multi-epitope vaccine, prokaryotic expression, immunization

中图分类号: